Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more infromation

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Nutrition in Clinical Practice
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Malone, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malone, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Invited Reviews

Altered Drug Disposition in Obesity and After Bariatric Surgery

Margaret Malone, PhD, FCCP

Department of Pharmacy Practice, Albany College of Pharmacy, New York

Correspondence: Margaret Malone, PhD, FCCP, Department of Pharmacy Practice, Albany College of Pharmacy, 106 New Scotland Avenue, Albany, NY 12208. Electronic mail may be sent to malonem{at}acp.edu.

The purpose of this review is to evaluate the effect of obesity and gastric bypass on drug disposition. A Medline search was conducted of literature from 1980 onward. All types of literature were included because of the limited data published on this subject. Very few prospective randomized controlled studies are available that have evaluated changes in drug pharmacokinetics and pharmacodynamics in patients who have a body mass index (BMI) >40 kg/m2 or who have undergone gastric restrictive surgery. Dosing recommendations have been based on general pharmacokinetic principles where specific drug data have not been assessed. Given the increasing prevalence of overweight and obesity in the population, studies that evaluate the impact of obesity on drug disposition, especially related to drugs released in the past 10 years, should be conducted.

Nutrition in Clinical Practice, Vol. 18, No. 2, 131-135 (2003)
DOI: 10.1177/0115426503018002131
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
A. D. Miller and K. M. Smith
Medication and nutrient administration considerations after bariatric surgery.
Am. J. Health Syst. Pharm., October 1, 2006; 63(19): 1852 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 Am J Crit CareHome page
M. M. Barth and C. E. Jenson
Postoperative nursing care of gastric bypass patients.
Am. J. Crit. Care., July 1, 2006; 15(4): 378 - 387.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. Malone and S. A Alger-Mayer
Medication Use Patterns After Gastric Bypass Surgery for Weight Management
Ann. Pharmacother., April 1, 2005; 39(4): 637 - 642.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. Malone
Enhancing Pharmacist Involvement in Weight Management--Time to Get with the Program
Ann. Pharmacother., November 1, 2004; 38(11): 1961 - 1963.
[Full Text] [PDF]